Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2005
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974824 N-substituted-4-(m-hydroxyphenyl)piperidine derivated and esters thereof, used to bind a kappa opioid receptor; treating drug addiction
12/13/2005US6974823 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/13/2005US6974800 Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor
12/13/2005US6974792 Alpha 1-antitrypsin preparation as well as a method for producing the same
12/13/2005US6974589 Neutral-cationic lipid for nucleic acid and drug delivery
12/13/2005US6974576 Extracts provided by the present invention have a higher immune stimulatory activity than extracts prepared and used in the art
12/13/2005US6973741 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116649A1 Method of screening vascular smooth muscle cell growth inhibitor and growth promoter
12/08/2005WO2005116207A1 Telomerase-inhibitory ena oligonucleotide
12/08/2005WO2005116194A1 Method of culturing myoblst or myoblast-like cell for forming myofiber in vitro
12/08/2005WO2005116066A1 Peptides derived from decorin leucine rich repeats and uses thereof
12/08/2005WO2005116013A1 Crystal of pharmaceutical compound
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2005116005A1 Epigallocatechin dimer and trimer having lipase inhibitory activity and/or antioxidative activity
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115409A1 Composition for inhibiting the onset of arteriosclerosis and inhibition method
12/08/2005WO2005115408A1 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
12/08/2005WO2003065982A3 Engineering absorption of therapeutic compounds via colonic transporters
12/08/2005WO2002057256A9 Piperazinylcarbonylquinolines and -isoquinolines
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272817 Dermatological use and a dermatological preparation
12/08/2005US20050272809 Remedies
12/08/2005US20050272806 Injectable formulations of taxanes for cad treatment
12/08/2005US20050272804 Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272760 Use of pyridoindolone derivatives for the preparation of medicinal products
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272729 Cytotoxic agents comprising taxanes and their therapeutic use
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272715 Optically active dihydropyridine derivative
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272685 Intraductal treatment targeting methylated promoters in breast cancer
12/08/2005US20050272684 Breast cancer resistance protein (BCRP) and the DNA which encodes it
12/08/2005US20050272683 Antisense oligonucleotides against thymidylate synthase
12/08/2005US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/08/2005US20050272669 treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. -[(4-{3-[N-(Carbamoylmethyl)-N-(methanesulfonyl)amino]-propoxy}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole
12/08/2005US20050272658 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)
12/08/2005US20050272647 Arthrodial cartilage extracellular matrix degradation inhibitor
12/08/2005US20050272641 Therapeutic agents for diabetes
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272036 Ketones
12/08/2005US20050271751 Active principle which is capable of inducing the conversion of inactive TGFb-latent into active TGFb
12/08/2005US20050271750 Topical formulation for prevention and treatment of acne
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271728 High molecular weight medicine-containing preparation in powder form for administration through mucosa
12/08/2005US20050271673 Trifunctional reagent for conjugation to a biomolecule
12/08/2005US20050271669 For therapy of proliferative disease
12/08/2005US20050271655 Nogo receptor antagonists
12/08/2005US20050271632 Methods of modulating hair growth
12/08/2005US20050271624 Use of apoptosis inducing agents in the treatment of (auto) immune diseases
12/08/2005US20050271603 Compositions comprising lactoferrin
12/08/2005US20050269546 Valve with a two-component seal
12/08/2005US20050268908 Medicament dispenser
12/08/2005DE4213005B4 Verwendung von Aromatasehemmern zur Empfängnisverhütung bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus Use of aromatase inhibitors for contraception in female primates without affecting the menstrual cycle
12/08/2005DE10085485B4 Verfahren zur Detektion des Mutationsgens dspp des hereditären opalisierenden Dentins Method for the detection of the mutation gene DSPP of hereditary opalescent dentin
12/08/2005DE10021731B4 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben Cyclipostins, processes for their preparation and pharmaceutical preparation thereof
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568766A1 Crth2 receptor ligands for medicinal uses
12/08/2005CA2568056A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2564668A1 Pyrrolidine derivatives
12/08/2005CA2509265A1 Methods of delaying alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and hmg coa reductase inhibitor
12/07/2005EP1602704A1 Antioxidant, skin preparation for external use, cosmetic and food
12/07/2005EP1602669A1 Antibody against tumor specific antigen as target
12/07/2005EP1602667A1 Aqueous formulation comprising TFPI and solubilising agents
12/07/2005EP1602665A1 Physiologically active peptides and drugs containing the same
12/07/2005EP1602660A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
12/07/2005EP1602659A1 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602655A1 Benzofuran derivative
12/07/2005EP1602652A1 Adiponectin expression promoter
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602645A1 Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
12/07/2005EP1602380A1 Preventive/remedy for diseases in upper digestive tract
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602372A1 Drug for improving prognosis for subarachnoid hemorrhage
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 1564